cultivate(MD) Capital Funds LP Announce Investment into Nanochon

Grand Rapids, Mich., November 27, 2023 — cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage medical device companies with innovative technologies, announced today that they have made a significant investment into Nanochon, a Washington, D.C.—based regenerative cartilage innovator.

Nanochon develops solutions utilized by sports medicine physicians to treat active patients requiring cartilage restoration. Nanochon’s Chondrograft™ replaces lost or damaged cartilage and encourages new growth using an innovative material and 3D printed designs that are cost-effective and easy to deploy treatment options.

Read the full press release here.

Scroll to Top

Do you or someone you care about have knee pain because of an articular cartilage lesion?

Surgeons in British Columbia are conducting a research study to evaluate an investigational device (a new device) to treat articular cartilage lesions in the knee.